These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27547772)

  • 21. Autoimmune mechanisms in myasthenia gravis.
    Cavalcante P; Bernasconi P; Mantegazza R
    Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infantile anti-MuSK positive myasthenia gravis in a patient with autoimmune polyendocrinopathy type 3.
    Duman O; Koken R; Baran RT; Haspolat S; Topaloglu H
    Eur J Paediatr Neurol; 2014 Jul; 18(4):526-8. PubMed ID: 24685514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
    Higuchi O; Hamuro J; Motomura M; Yamanashi Y
    Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological profile of the patients with MuSK positive myasthenia gravis.
    Nikolic A; Basta I; Stojanovic VR; Stevic Z; Lavrnic D
    Neurol Res; 2014 Nov; 36(11):945-9. PubMed ID: 24825477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of B cells in muscle-specific kinase antibody myasthenia gravis.
    Guptill JT; Yi JS; Sanders DB; Guidon AC; Juel VC; Massey JM; Howard JF; Scuderi F; Bartoccioni E; Evoli A; Weinhold KJ
    Neurol Neuroimmunol Neuroinflamm; 2015 Apr; 2(2):e77. PubMed ID: 25745635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
    Zoda T; Yeh TM; Krolick KA
    J Immunol; 1991 Jan; 146(2):663-70. PubMed ID: 1987281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete stable remission and autoantibody specificity in myasthenia gravis.
    Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
    Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
    Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrodiagnostic Characteristics Suggestive of Muscle-Specific Kinase Myasthenia Gravis.
    Skolka M; Lamb CJ; Rubin DI; Klein CJ; Laughlin RS
    Neurol Clin Pract; 2022 Jun; 12(3):211-217. PubMed ID: 35747537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.
    Rostedt Punga A; Ahlqvist K; Bartoccioni E; Scuderi F; Marino M; Suomalainen A; Kalimo H; Stålberg EV
    Clin Neurophysiol; 2006 Jul; 117(7):1434-43. PubMed ID: 16737845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis.
    Mori S; Yamada S; Kubo S; Chen J; Matsuda S; Shudou M; Maruyama N; Shigemoto K
    J Neuroimmunol; 2012 Mar; 244(1-2):1-7. PubMed ID: 22222307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs.
    Losen M; Martinez-Martinez P; Molenaar PC; Lazaridis K; Tzartos S; Brenner T; Duan RS; Luo J; Lindstrom J; Kusner L
    Exp Neurol; 2015 Aug; 270():18-28. PubMed ID: 25796590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population.
    Chang T; Leite MI; Senanayake S; Gunaratne PS; Gamage R; Riffsy MT; Jacobson LW; Adhikari M; Perera S; Vincent A
    J Neurol Sci; 2014 Aug; 343(1-2):82-7. PubMed ID: 24929651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.
    Zhang B; Tzartos JS; Belimezi M; Ragheb S; Bealmear B; Lewis RA; Xiong WC; Lisak RP; Tzartos SJ; Mei L
    Arch Neurol; 2012 Apr; 69(4):445-51. PubMed ID: 22158716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis.
    Allman W; Saini SS; Tuzun E; Christadoss P
    Cell Immunol; 2011; 271(2):292-8. PubMed ID: 21861992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Xenopus tissue cultures for the study of myasthenia gravis pathogenesis.
    Yeo HL; Lim JY; Fukami Y; Yuki N; Lee CW
    Dev Biol; 2015 Dec; 408(2):244-51. PubMed ID: 25746216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.